Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Sleasman

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 17, 2020
Total serum immunoglobulin A in ALSJesse Crayle, Mai Elmallah, John Sleasman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 18, 2016
Brief Report: Macrophage Activation in HIV-Infected Adolescent Males Contributes to Differential Bone Loss by Sex: Adolescent Trials Network Study 021Alexandra Ruan, Nicole H Tobin, Kathleen Mulligan, et al.
The Journal of Allergy and Clinical Immunology|April 10, 2007
Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric patients with moderate immune suppression: results of Pediatric AIDS Clinical Trials Study 402Savita Pahwa, Petronella Muresan, John Sleasman, et al.
Journal of Clinical Immunology|June 10, 2016
Flebogamma(®) 5 % DIF Intravenous Immunoglobulin for Replacement Therapy in Children with Primary Immunodeficiency DiseasesMark Ballow, Paul J Pinciaro, Timothy Craig, et al.
AIDS Research and Human Retroviruses|June 19, 2009
Short-cycle therapy in adolescents after continuous therapy with established viral suppression: the impact on viral load suppressionBret J Rudy, John Sleasman, Bill Kapogiannis, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 3, 2014
Fiscal implications of newborn screening in the diagnosis of severe combined immunodeficiencyCatherine Kubiak, Soma Jyonouchi, Caroline Kuo, et al.
Pediatric Research|October 19, 2013
Lipopolysaccharide and soluble CD14 in cord blood plasma are associated with prematurity and chorioamnionitisDenise G Martinez-Lopez, Nicholas T Funderburg, Adam Cerissi, et al.
Cardiology in the Young|December 14, 2011
Management of children undergoing cardiac transplantation with high Panel Reactive AntibodiesAlfred Asante-Korang, Jeffrey P Jacobs, Jeremy Ringewald, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2012
Low bone mass in behaviorally HIV-infected young men on antiretroviral therapy: Adolescent Trials Network Study 021BKathleen Mulligan, D Robert Harris, Patricia Emmanuel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 2, 2009
Obesity and dyslipidemia in behaviorally HIV-infected young women: Adolescent Trials Network study 021Kathleen Mulligan, D Robert Harris, Dina Monte, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 17, 2020
Total serum immunoglobulin A in ALSJesse Crayle, Mai Elmallah, John Sleasman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 18, 2016
Brief Report: Macrophage Activation in HIV-Infected Adolescent Males Contributes to Differential Bone Loss by Sex: Adolescent Trials Network Study 021Alexandra Ruan, Nicole H Tobin, Kathleen Mulligan, et al.
The Journal of Allergy and Clinical Immunology|April 10, 2007
Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric patients with moderate immune suppression: results of Pediatric AIDS Clinical Trials Study 402Savita Pahwa, Petronella Muresan, John Sleasman, et al.
Journal of Clinical Immunology|June 10, 2016
Flebogamma(®) 5 % DIF Intravenous Immunoglobulin for Replacement Therapy in Children with Primary Immunodeficiency DiseasesMark Ballow, Paul J Pinciaro, Timothy Craig, et al.
AIDS Research and Human Retroviruses|June 19, 2009
Short-cycle therapy in adolescents after continuous therapy with established viral suppression: the impact on viral load suppressionBret J Rudy, John Sleasman, Bill Kapogiannis, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 3, 2014
Fiscal implications of newborn screening in the diagnosis of severe combined immunodeficiencyCatherine Kubiak, Soma Jyonouchi, Caroline Kuo, et al.
Pediatric Research|October 19, 2013
Lipopolysaccharide and soluble CD14 in cord blood plasma are associated with prematurity and chorioamnionitisDenise G Martinez-Lopez, Nicholas T Funderburg, Adam Cerissi, et al.
Cardiology in the Young|December 14, 2011
Management of children undergoing cardiac transplantation with high Panel Reactive AntibodiesAlfred Asante-Korang, Jeffrey P Jacobs, Jeremy Ringewald, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2012
Low bone mass in behaviorally HIV-infected young men on antiretroviral therapy: Adolescent Trials Network Study 021BKathleen Mulligan, D Robert Harris, Patricia Emmanuel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 2, 2009
Obesity and dyslipidemia in behaviorally HIV-infected young women: Adolescent Trials Network study 021Kathleen Mulligan, D Robert Harris, Dina Monte, et al.
Pageof 2